000			01265 a2200313 4500
005			20250513224919.0
264		0	_c20010301
008			200103s 0 0 eng d
022			_a0149-2918
024	7		_a10.1016/s0149-2918(00)83063-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aBarnebey, H
245	0	0	_aPatients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting. _h[electronic resource]
260			_bClinical therapeutics _cOct 2000
300			_a1204-12 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aCarbonic Anhydrase Inhibitors _xadverse effects
650	0	4	_aGlaucoma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIntraocular Pressure _xdrug effects
650	0	4	_aPatient Satisfaction
650	0	4	_aProspective Studies
650	0	4	_aSulfonamides _xadverse effects
650	0	4	_aThiazines _xadverse effects
650	0	4	_aThiophenes _xadverse effects
700	1		_aKwok, S Y
773	0		_tClinical therapeutics _gvol. 22 _gno. 10 _gp. 1204-12
856	4	0	_uhttps://doi.org/10.1016/s0149-2918(00)83063-5 _zAvailable from publisher's website
999			_c11051510 _d11051510